Navigation Links
New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study
Date:10/6/2008

hioprine monotherapy who died following a colectomy and one patient receiving REMICADE combination therapy who was diagnosed with tuberculosis. Serious infections were reported as follows: 8 in the azathioprine monotherapy group, 4 in the REMICADE monotherapy group and 6 in the REMICADE combination therapy group.

In 1998 REMICADE became the first anti-TNF-alpha therapy approved by the FDA for the treatment of moderately to severely active Crohn's disease for the reduction of the signs and symptoms in patients who have an inadequate response to conventional therapy. During the past decade, REMICADE has also become the first and only anti-TNF-alpha therapy that the FDA has approved for the treatment of ulcerative colitis, a related inflammatory bowel disease, and pediatric Crohn's disease.

Crohn's disease is a chronic inflammatory disease of the colon and large intestine that affects approximately 500,000 people in the United States. Crohn's disease can lead to frequent hospitalizations, surgery and loss of work productivity.

About SONIC

SONIC is a multicenter, Phase 3b, randomized, double-blind, controlled clinical trial designed to compare the efficacy and safety of REMICADE monotherapy, azathioprine monotherapy and combination therapy with the 2 drugs in patients with moderate to severe Crohn's disease who were nave to immunomodulator and biologic therapy. A total of 508 patients with Crohn's disease who were naive to both biologics and immunomodulators (azathioprine, 6-mercaptopurine and methotrexate) were enrolled in the study and were randomized into three groups; 170 patients received azathioprine 2.5 mg/kg/day and placebo infusions, 169 patients received REMICADE 5 mg/kg infusions at weeks 0, 2, 6 and every 8 weeks thereafter with placebo capsules and 169 patients received REMICADE 5 mg/kg and azathioprine 2.5 mg/kg through 30 weeks. The primary endpoint of SONIC was to assess the induction of steroid-free remission. Fifty-two perce
'/>"/>

SOURCE Centocor
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. More Findings on Gene Involved in Childhood Asthma
2. Interleukin Genetics to Present Important New Findings at 2008 World Congress on Osteoarthritis
3. VAI Findings Could Aid Diagnosis and Treatment of Several Types of Kidney Cancer
4. Findings on Bladder-Brain Link May Point to Better Treatments for Problems in Sleep, Attention
5. Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
6. FDA Updates Label for AVANDIA(R) to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years
7. Tengion Scientists Publish Key Preclinical Findings Demonstrating the Benefits of Organ Regeneration Vs. Repair
8. Study Findings Show Infection Control Intervention Helps Keep Kids in School
9. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
10. ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
11. ACORN Presents Findings of Collaborative Metastatic Colorectal Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July 29, 2014   ... II study investigating the efficacy and safety of MSB0010718C in ... is a rare and aggressive skin cancer lacking effective treatments   ... seven cohort Phase I clinical trial for the treatment of ... EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, ...
(Date:7/28/2014)... -- Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC ) ... audio webcast to discuss financial results for the second quarter ... 31, 2014 at 4:30 p.m. ET. Conference ... 31, 2014 Time: 4:30 PM ET Listen via Internet: ... A webcast replay will be available on the Pharmacyclics ...
(Date:7/28/2014)... FRANCISCO , July 28, 2014  Dignity ... it has received the Get With The Guidelines®-Stroke ... improvement measures outlined by the American Heart Association/American ... Stroke is the number four cause of death ... the United States , according ...
Breaking Medicine Technology:EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 2EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 4EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 5Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 3
(Date:7/29/2014)... In his latest blog post at http://www.perwickstrom.com , ... has listed 6 ways to light the “fire” in employees. ... complacency, but for some it’s a losing battle,” commented ... ways to help employees get to the next level; which ... , According to Per Wickstrom, 6 ways to light the ...
(Date:7/29/2014)... 2014 In its latest blog post, ... and believes that having family close by during a ... whether or not the process is successful, has busted ... difficult to estimate just how damaging and destructive these ... Per Wickstrom . “Not only do they ensnare new ...
(Date:7/29/2014)... A Forever Recovery , an open-ended drug ... great start and gives them a solid foundation in recovery ... National Cherry Festival kickoff concert held on July 5, 2014 ... by Miller Lite and in partnership with WKLT Radio, saw ... Music Stage presented by Blue Cross Blue Shield and rock ...
(Date:7/29/2014)... July 29, 2014 Septic tanks ... of 5. This score reflects a buyer's moderate ability ... large number of suppliers, the product's widespread availability and ... IBISWorld analyst Jordan Weinstein. IBISWorld estimates that there are ... substantial number of supplier options. However, recent demand growth ...
(Date:7/29/2014)... Launched in 2012 by veteran anesthesiologist ... hangovers earlier this year at its Vegas location. Having ... the publication of research data related to the 20,000 ... The only licensed medical practice dedicated to the study, ... 2012 and treated thousands of patients within the first ...
Breaking Medicine News(10 mins):Health News:Per Wickstrom’s Latest Blog Post Lists 6 Ways to Light the “Fire” in Employees 2Health News:Latest Best Drug Rehabilitation Blog Post Busts 4 Big Addiction Myths 2Health News:Latest Best Drug Rehabilitation Blog Post Busts 4 Big Addiction Myths 3Health News:A Forever Recovery Sponsors National Cherry Festival Kickoff Concert Featuring Collective Soul on July 5 in Traverse City, MI 2Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 2Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 3Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 4Health News:Hangover Heaven Surpasses 20,000 Hangovers 2Health News:Hangover Heaven Surpasses 20,000 Hangovers 3
... HealthCore Finds Optimal Outcomes, Can Be ... Controllers, INDIANAPOLIS, July 8 Compliance ... outcomes, as measured by,reduced emergency room visits ... conducted by HealthCore, Inc., the health outcomes,research ...
... SUNNYVALE, Calif., July 8 ,Associates of Cape Cod, ... announce the launch of ACC,s Chromogenic LAL Endotoxin ... SoftMax(R) Pro GxP software., ACC and MDS ... part,11 solution for ACC,s Chromogenic LAL Endotoxin assay ...
... "a symmetric threat that imperils all nations", ... for Strategic Threat Analysis and Response (ISTAR),University of ... The following is by,Harvey Rubin, M.D., Ph.D., ... (ISTAR) University of Pennsylvania School of,Medicine:, The ...
... associated with mental disorders represent one of the ... today. This challenge is marked by the immense ... are their persistent increase due to an aging ... and, finally, the large unmet treatment needs, combined ...
... July 8, 2008 An analysis of more ... that darker-skinned patients benefit as those with lighter skin ... UT Southwestern Medical Center researchers show. , Phototherapy is ... ranging from common problems such as acne and psoriasis ...
... age of American moms may be behind increase in cases, ... heart attacks are rare among young women, becoming pregnant does ... , "This is a unique phenomenon in the sense ... have [heart attacks]," said lead researcher Dr. Uri Elkayam, a ...
Cached Medicine News:Health News:Study Measures Real-World Comparative Effectiveness of Asthma Controller Medications 2Health News:Study Measures Real-World Comparative Effectiveness of Asthma Controller Medications 3Health News:Study Measures Real-World Comparative Effectiveness of Asthma Controller Medications 4Health News:Associates of Cape Cod (ACC) and MDS Analytical Technologies Collaborate to Offer a More Robust LAL Endotoxin Assay Platform 2Health News:Associates of Cape Cod (ACC) and MDS Analytical Technologies Collaborate to Offer a More Robust LAL Endotoxin Assay Platform 3Health News:Proposing a New Global Compact for Infectious Diseases 2Health News:Proposing a New Global Compact for Infectious Diseases 3Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 2Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 3Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 4Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 5Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 6Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 7Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 8Health News:New research reveals ultraviolet light therapy is as beneficial for darker skin as lighter skin 2Health News:Pregnancy Boosts Heart Attack Risk 2
This is adapted to microplate or card....
Bio-Rad's ScanGel® cards for blood typing provide standardized protocols for all the cards: same incubation time (if required), same centrifugation time and speed....
Bio-Rad's ScanGel® cards for ABO reverse grouping, antibody screening and crossmatching include - ScanGel Neutral, ScanGel Coombs, Anti-IgG, -C3d (AHG), ScanGel Coombs + Neutral, ScanGel Anti-Ig...
... cell accommodates up to 12 large slab ... in the PROTEAN IEF system, for high-throughput ... PROTEAN Plus Dodeca cell's cooling and recirculating ... consistent, high-resolution results. The handcasting system includes ...
Medicine Products: